Present Position: IVF Consultant

Working as IVF consultant in Akanksha IVF, Mata Chanan Devi Hospital, Delhi since 2020

Dr. Sabina Sanan is a dedicated IVF consultant with a strong background in reproductive medicine, currently practicing at Akanksha IVF Centre, Mata Chanan Devi Hospital, Delhi, since 2020. With a patient-focused approach and deep clinical insight, Dr. Sanan specializes in fertility evaluations, ovulation induction, IUI, IVF, and patient counseling. She is committed to providing personalized care to individuals and couples facing infertility, guiding them with compassion and evidence-based treatment protocols. Dr. Sanan stays updated with the latest advancements in assisted reproductive technology (ART) and works closely with multidisciplinary teams to ensure the highest standards of care. Known for her empathy, clear communication, and ethical practice, she has earned the trust of many patients across Delhi. Her mission is to help people achieve their dream of parenthood through safe, effective, and individualized fertility solutions.

Education

• Sir Ganga Ram Hospital, New Delhi, Fellowship of National Board in Reproductive Medicine (FNB) | April 2016 – April 2018
• Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India | May 2012 – April 2015 | Masters in Surgery (MS), Obstetrics & Gynecology
• Jawahar Lal Nehru Medical College, Belgaum | June 2003 – Feb 2009 | Bachelor of Medicine, Bachelor of Surgery (MBBS)
  • Completed one year of mandatory Internship in various clinical departments

Work Experience

• IVF Consultant in Medicover Rohini (August 2019 – December 2019)
• Sir Ganga Ram Hospital, New Delhi, Residency (2016 – 2018)
• Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India | Senior Residency (January 2016 to March 2016)
• MMU Solan, Senior Residency (August 2015 – December 2015)

Most Recent Presentations in Conferences

• Covid recent trends – chapter 2021
• Etiopathogenesis of endometriosis – Dr KD Nayar, Dr Sabina Sanan 2021
• A preliminary experience of Validation and Integration of an Electronic Witness System (EWS) into a busy Indian IVF laboratory” for possible publication in The Journal of Obstetrics and Gynecology of India 2019.
• Oral paper presented on ‘Role of progesterone in intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions’, at the first world congress held in India by International Federation of Fertility Society (IFFS) in September 2016.
• Oral paper presented on ‘Is preeclampsia predictor of maternal health’ at the annual conference held by the Federation of Obstetrical and Gynaecological Societies of India (FOGSI) at the AICOG on 26th of 2016, at Ahmedabad.
• Oral paper presented on ‘Role of endometrial receptivity assay in recurrent implantation failure’ at annual conference held by Academy of Clinical Embryologist of India (ACE), in September 2017, at Hyderabad.
• Oral paper presented on ‘Does administration of intrauterine human chorionic gonadotropin, immediately after oocyte retrieval, have an effect on IVF outcome?’ at the annual conference Fertivision 2017 held at New Delhi in December 2017. (Awarded best oral paper presentation).
• A mock Examination for all reproductive medicine fellowship students from various Indian universities held at Milan Centre of Human reproduction, Bangalore (January 2017) – Stood First.
• Participated in the quiz at the Fertivision 2017 annual conference in December 2017.
• Role of VBAC in previous LSCS – AICOG Patna 2014.

Publications

• ‘Does progesterone exposure increase the risk of intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions?’ – Published in International Journal of Scientific Research (PubMed Indexed), October 2017.
• ‘Accessory cavitory uterine mass’ – Sent for review in Annals of Medical and Health Science Research (PubMed Indexed).

Awards

• Best oral paper presentation at Fertivision conference.
• Best resident in super speciality in reproductive medicine at Sir Ganga Ram Hospital, New Delhi in 2018.

Societies

• Member of ACE (Academy of Clinical Embryologist of India).
• Member of AOGD and FOGSI

Age and Female Fertility: Navigating Biology with Advanced IVF Solutions

Human reproductive health is deeply governed by biological timelines. Across various aspects of physiological well-being, our natural systems undergo gradual changes over time. Beyond natural chronological aging, a person’s biological reproductive age can be further accelerated by modern lifestyle stressors, environmental pollution, underlying metabolic conditions, and inadequate nutritional intake. For individuals and couples planning a family, understanding these biological shifts is crucial for timely family planning.

The Biological Link Between Age and Conception

The biological capacity to conceive and carry a healthy pregnancy is a fundamental aspect of reproductive medicine. While age-related reproductive changes affect both partners, the timeline is more clearly defined for women due to a fixed ovarian reserve.

A woman is born with her entire lifetime supply of oocytes (eggs). These eggs remain dormant until puberty and decline steadily in both quantity and quality with each passing year. Consequently, the statistical probability of achieving a successful, full-term pregnancy decreases with advancing age. For context, reproductive studies show that a healthy woman in her early 20s has approximately a 1-in-3 chance of conceiving naturally during any given menstrual cycle; by age 40, that statistical probability shifts to approximately a 1-in-20 chance per cycle.

How Modern Assisted Reproductive Technology (ART) Helps

Fortunately, advancements in Assisted Reproductive Technology (ART) provide reliable options to overcome age-related fertility challenges. At premier facilities like Akanksha IVF Centre—recognized as a leading IVF clinic in Delhi—specialists use customized protocols to optimize conception rates:

• In Vitro Fertilization (IVF): Through controlled ovarian stimulation protocols, fertility specialists encourage the development of multiple mature oocytes. These are safely retrieved and fertilized with sperm in a highly regulated laboratory setting to create viable embryos, which are then precisely transferred to the uterus.
• Oocyte Cryopreservation (Egg Freezing): Women who wish to preserve their current fertility for career, personal, or medical reasons can elect to freeze their mature, high-quality eggs, effectively pausing the biological clock for future use.
• Donor Egg Programs: For women facing diminished ovarian reserves or age-related egg quality challenges, utilizing healthy eggs provided by a young donor significantly maximizes the probability of successful embryo implantation and a healthy pregnancy.

While navigating age-related fertility shifts requires careful clinical consideration, modern reproductive medicine makes successful, healthy pregnancies entirely achievable for women in their late 30s and 40s. Proactive consulting and personalized treatment paths remain the key to a successful journey.